Fosun and KKR extend deadline for $1.2bn Gland Pharma deal
Shanghai Fosun Pharma and KKR have agreed to extended the termination date for the former's proposed $1.2bn (€1bn) takeover of Gland Pharma.
Archives for July 31, 2017
More fake Xeplion withdrawn in Denmark
A fourth batch of Janssen-Cilag’s schizophrenia drug Xeplion has been withdrawn in Denmark after the identification of counterfeit packs.
Lupin says it fixed issue flagged by US FDA during Aurangabad audit
Lupin says it has already resolved a problem flagged in a Form 483 issued by US FDA inspectors who visited its Aurangabad manufacturing facility in July.
STA: merger with WuXi division follows single source contract provider trend
STA Pharmaceutical has merged with WuXi AppTec’s Pharmaceutical Development Services (PDS) to create a “more complete and integrated platform.”
Icon focused on smooth transition, minimal turnover, says CEO on Mapi acquisition
Integration of the Mapi Group has been initiated, Icon CEO Steve Cutler says, as the company looks to support customers facing increased pressure to demonstrate product value and safety.